Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00412_DB00755_nanopub.RAOTqRtB6Q8N1Mbh2Y35s4UkzcGsEyq2RqwXCR5As2Ry8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00412_DB00755 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00412_DB00755 label "DDI between Rosiglitazone and Tretinoin - The moderate CYP2C8 inhibitor, Rosiglitazone, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Rosiglitazone is initiated, discontinued to dose changed. [drugbank_resource:DB00412_DB00755]" assertion.
- drugbank_resource:DB00412_DB00755 identifier "drugbank_resource:DB00412_DB00755" assertion.
- drugbank_resource:DB00412_DB00755 title "DDI between Rosiglitazone and Tretinoin - The moderate CYP2C8 inhibitor, Rosiglitazone, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Rosiglitazone is initiated, discontinued to dose changed." assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00412_DB00755 assertion.
- drugbank:DB00412 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00412_DB00755 assertion.